Cat allergy immunotherapy (Circassia)

N/A

Report date: 2023/07/18 20:00:33

Base Information

Drug NameCat allergy immunotherapy (Circassia)
Drug Alias NameCat allergen vaccine猫过敏免疫治疗Cat Synthetic Peptide Immuno-Regulatory EpitopesToleroMuneCat peptide allergen desensitisation +[7] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAnaphylaxisCarcinomaRhinitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[9] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCircassia Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCircassia LtdNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsAnaphylaxisCarcinomaRhinitis

Other Information

ATC CodeN/A
Related LinksN/A